Phase II Trial of Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage: BLOcking the Cytokine IL-1 in ICH
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2019
Price : $35 *
At a glance
- Drugs Anakinra (Primary)
- Indications Cerebral haemorrhage
- Focus Therapeutic Use
- Acronyms BLOC-ICH
- 02 Aug 2019 Planned End Date changed from 27 Apr 2020 to 29 May 2020.
- 02 Aug 2019 Planned primary completion date changed from 31 Jan 2020 to 28 Feb 2020.
- 13 Jun 2019 Status changed from not yet recruiting to recruiting.